Malaysia reports first mpox case of the year; man tests positive for less severe variant
The man, who had fever and a rash, had not travelled abroad in the 21 days prior to the onset of symptoms.
KUALA LUMPUR: Malaysia on Tuesday (Sep 17) reported its first mpox case of the year after a man who had not been abroad in recent weeks tested positive for the less severe clade II variant.
The case was detected on Monday in a man who began showing symptoms of fever, sore throat, and cough on Sep 11, with a rash appearing the following day, the health ministry said in a statement.
The patient, a Malaysian national, had not travelled abroad in the 21 days prior to the onset of symptoms, the ministry added.
"All contacts of this patient are being identified, and their health status will be monitored according to strict standard operating procedures."
Malaysia has detected a total of 10 cases of mpox since July last year, all of which are of the clade II variant.
Nine of those cases were logged in 2023.
A new form of the virus has triggered global concern as it seems to spread easily though routine close contact, leading to flu-like symptoms and pus-filled lesions.
Last month, the World Health Organization declared mpox a global public health emergency, its highest form of alert, for the second time in two years, following an outbreak in the Democratic Republic of Congo that had spread to neighbouring countries.
The disease is usually mild but can kill, with children, pregnant women and people with weakened immune systems, such as those with HIV, all at higher risk of complications.
While mpox has been known for decades, a new deadlier and more transmissible strain - known as Clade 1b - has driven the recent surge in cases.
Clade 1b causes death in about 3.6 per cent of cases, with children more at risk, according to the World Health Organization.
Singapore earlier this month said that it would offer the mpox vaccine to healthcare workers who are at the highest risk of exposure to the disease as well as close contacts of confirmed cases.
The vaccine JYNNEOS - which has been used in Singapore for protection against mpox and smallpox - will be offered free to both groups.
Singapore has already implemented temperature and visual screening for certain inbound travellers and crew at Changi and Seletar airports as a precautionary measure.
Similar screening measures will also be implemented at sea checkpoints for crew and passengers arriving on ships from mpox affected areas, the health ministry said in August.
There have been 15 mpox cases in Singapore so far this year, all of them clade II.